After receiving EOB
Download and share the patient flashcard about the NGS Affordability Program with your patients. It provides a summary of the program and how to enroll.
Please check patients’ commercial insurance coverage, as coverage for NGS varies. See Terms and Conditions below.
See NGS Affordability Program enrollment form for full eligibility details; other restrictions may apply. Terms and Conditions
With Biomarker Assist, eligible patients may pay as little as $0 out-of-pocket, up to the program maximum of $1000.*
Unfortunately, you may not sign up for the program on the patient’s behalf. The patient is responsible for answering the co-pay eligibility questions and providing their attestation to confirm eligibility for the Biomarker Assist NGS Affordability Program. Please have your patient visit www.biomarkerassist.com or call us at (866) AMG - ASST (1-866-264-2778). We are available Monday through Friday, 9:00 am to 8:00 pm ET.
If the patient has paid their out-of-pocket responsibility to the lab, patient needs to complete enrollment, provide patient authorization, and send in an Explanation of Benefits (EOB) with proof of payment. If the patient has not paid their out-of-pocket responsibility to the lab, a patient needs to complete enrollment, provide patient authorization, and send in an EOB.
The patient may enroll online or by downloading the form and sending it with required documents to Biomarker Assist via fax at 1-866-671-9373, or mail to ConnectiveRx, Attn Biomarker Assist NGS Affordability Program, PO Box 2355 Morristown, NJ 07962. Once received, Biomarker Assist will review the EOB form, determine your patient’s benefit, then send a check to the patient or lab with the appropriate amount. EOBs must be faxed to Biomarker Assist within 180 days of the date of service, otherwise your patient will not be eligible for this program and the patient will be responsible for all out-of-pocket costs.
NGS=Next Generation Sequencing
*One-time benefit up to $1000 maximum. Program limitations apply, please see terms and conditions including limits on individual program coverages. Programs valid for testing performed through December 31, 2023.